Costa Rica vs Libya: Cause of death, by non-communicable diseases, ages 15-59, male
Costa Rica
47.8%
in 2021
Libya
47.6%
in 2021
Costa Rica rank
103rd
Libya rank
104th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Costa Rica
- Libya
How they compare
Costa Rica currently reports 47.8% against 47.6% in Libya, a difference of 0.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Costa Rica ahead.
Costa Rica ranks 103rd and Libya ranks 104th of 185 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.3% | 50.7% | 1.7% | Costa Rica |
| 2010s | 52.1% | 47.7% | 4.4% | Costa Rica |
| 2020s | 50.3% | 47.8% | 2.5% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Costa Rica or Libya?
- Costa Rica, at 47.8% against 47.6% in Libya as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Costa Rica and Libya?
- 0.2%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Libya?
- 6 years are reported by both, from 2000 to 2021.
- How do Costa Rica and Libya rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Costa Rica ranks 103rd and Libya ranks 104th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.